Literature DB >> 22560628

β-Lapachone analogs with enhanced antiproliferative activity.

Carla Ríos-Luci1, Evelyn L Bonifazi, Leticia G León, Juan C Montero, Gerardo Burton, Atanasio Pandiella, Rosana I Misico, José M Padrón.   

Abstract

In this study, we describe the synthesis of a series of α- and β-lapachone containing hydroxyl or methoxyl groups on the benzene ring, by means of the selective acid promoted cyclization of the appropriate lapachol analog. The evaluation of the antiproliferative activity in human solid tumor cell lines provided 7-hydroxy-β-lapachone as lead with enhanced activity over the parent drug β-lapachone. Cell cycle studies, protein expression experiments, and reactive oxygen species analysis revealed that, similarly to β-lapachone, ROS formation and DNA damage are critical factors in the cellular toxicity of 7-hydroxy-β-lapachone.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22560628     DOI: 10.1016/j.ejmech.2012.04.008

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   7.088


  2 in total

1.  Encapsulation of nor-β-lapachone into poly(d,l)-lactide-co-glycolide (PLGA) microcapsules: full characterization, computational details and cytotoxic activity against human cancer cell lines.

Authors:  Marcília P Costa; Anderson C S Feitosa; Fátima C E Oliveira; Bruno C Cavalcanti; Gleiston G Dias; Ewerton W S Caetano; Francisco A M Sales; Valder N Freire; Stefano Di Fiore; Rainer Fischer; Luiz O Ladeira; Eufrânio N da Silva Júnior; Claudia Pessoa
Journal:  Medchemcomm       Date:  2017-09-07       Impact factor: 3.597

2.  Lapachol and synthetic derivatives: in vitro and in vivo activities against Bothrops snake venoms.

Authors:  Marcelo A Strauch; Marcelo Amorim Tomaz; Marcos Monteiro-Machado; Bruno Lemos Cons; Fernando Chagas Patrão-Neto; Jhonatha da Mota Teixeira-Cruz; Matheus da Silva Tavares-Henriques; Pâmella Dourila Nogueira-Souza; Sara L S Gomes; Paulo R R Costa; Edgar Schaeffer; Alcides J M da Silva; Paulo A Melo
Journal:  PLoS One       Date:  2019-01-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.